RecallRadar

FDA Drug recall D-0262-2023

Diltiazem Hydrochloride Extended-Release Capsules, USP, 360 mg

On 2023-02-08 the FDA classified a Class II recall of Diltiazem Hydrochloride Extended-Release Capsules, USP, 360 mg by Sun Pharmaceutical Industries, citing failed Impurity (Deacetyl Diltiazem Hydrochloride) specification during stability testing and failed dissolution testing at FDA laboratory.

Read the official FDA Drug notice

AgencyFDA Drug
Recall numberD-0262-2023
ClassificationClass II
Statusterminated
Initiated2023-01-13
Published2023-02-08
Last updated2026-09-13 11:52 UTC
CompanySun Pharmaceutical Industries
DistributionUS

Product

Diltiazem Hydrochloride Extended-Release Capsules, USP, 360 mg; Rx only; 90-count bottles, Manufactured by: Sun Pharmaceutical Industries Ltd. Halol-Baroda Highway, Halol-389350, Gujarat, India; Distributed by: Sun Pharmaceutical Industries, Inc. Cranbury, NJ 08512, NDC 47335-679-81

Reason

Failed Impurity (Deacetyl Diltiazem Hydrochloride) specification during stability testing and failed dissolution testing at FDA laboratory.

Identifiers

ndc47335-675-83
ndc47335-675-81
ndc47335-675-19
ndc47335-675-13
ndc47335-675-18
ndc47335-676-83
ndc47335-676-81
ndc47335-676-19
ndc47335-676-13
ndc47335-676-18
ndc47335-677-83
ndc47335-677-81
ndc47335-677-19
ndc47335-677-13
ndc47335-677-18
ndc47335-678-83
ndc47335-678-81
ndc47335-678-19
ndc47335-678-13
ndc47335-678-18
ndc47335-679-83
ndc47335-679-81
ndc47335-679-19
ndc47335-679-13
ndc47335-679-18
code_infoLot #: HAC3120A, HAC3121A, Exp. 04/2023; HAC4460A, Exp. 10/2023; HAD0365A, Exp. 12/2023; HAD1452A, Exp. 02/2024.

Status history

No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: terminated.

Source

Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0262-2023%22

RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.